RECRUITING

Pediatric Cochlear Implant Remote Programming and Assessment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measures via iOS mobile application.

Official Title

Pediatric Cochlear Implant Remote Programming and Assessment

Quick Facts

Study Start:2025-01-15
Study Completion:2026-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07035873

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 20 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Cochlear implantation with an Advanced Bionics cochlear implant in at least one ear.
  2. * At least 6 months post-implantation listening experience and at least 2 weeks of listening experience with Marvel cochlear implant external processor.
  3. * Speech perception performance of at least 40% correct on standard of care speech perception measures in quiet for the ear to be used in the study
  4. * Ages 13 years to 20 years, inclusive
  5. * Ability and willingness to participate in remote programming sessions and self-administered assessment measures
  1. * Children under the age of 13
  2. * Speech perception performance \< 40% on SOC speech perception measures
  3. * Cognitive or language deficits that preclude ability and willingness to participate in remote programming sessions and self-administered assessment measures, as identified by eMR diagnoses and the participant's primary clinical audiologist judgement.

Contacts and Locations

Study Contact

Ursula M Findlen, PhD
CONTACT
614-722-6526
ursula.findlen@nationwidechildrens.org
Nationwide Children's Hospital- Audiology Department
CONTACT
614-722-3951
ursula.findlen@nationwidechildrens.org

Principal Investigator

Ursula M Findlen, PhD
PRINCIPAL_INVESTIGATOR
Nationwide Children's Hospital

Study Locations (Sites)

Nationwide Children's Hospital
Columbus, Ohio, 43205
United States

Collaborators and Investigators

Sponsor: Nationwide Children's Hospital

  • Ursula M Findlen, PhD, PRINCIPAL_INVESTIGATOR, Nationwide Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-15
Study Completion Date2026-03-31

Study Record Updates

Study Start Date2025-01-15
Study Completion Date2026-03-31

Terms related to this study

Keywords Provided by Researchers

  • pediatric
  • cochlear implant
  • remote programming
  • telehealth

Additional Relevant MeSH Terms

  • Cochlear Implant Listeners